Invention Grant
US07919467B2 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
有权
用于癌症预防，治疗和诊断的细胞毒性T淋巴细胞诱导免疫原
- Patent Title: Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
- Patent Title (中): 用于癌症预防，治疗和诊断的细胞毒性T淋巴细胞诱导免疫原
-
Application No.: US11426161Application Date: 2006-06-23
-
Publication No.: US07919467B2Publication Date: 2011-04-05
- Inventor: Venky Ramakrishna , Mark M. Ross , Ramila Philip , Lorraine H. Keller
- Applicant: Venky Ramakrishna , Mark M. Ross , Ramila Philip , Lorraine H. Keller
- Applicant Address: US PA Doylestown
- Assignee: Immunotope, Inc.
- Current Assignee: Immunotope, Inc.
- Current Assignee Address: US PA Doylestown
- Agency: Ballard Spahr LLP
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61P35/00
Abstract:
The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as ovarian carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a CTL response against cancer.
Public/Granted literature
- US20080207497A1 CYTOTOXIC T-LYMPHOCYTE-INDUCING IMMUNOGENS FOR PREVENTION, TREATMENT, AND DIAGNOSIS OF CANCER Public/Granted day:2008-08-28
Information query
IPC分类:
